Concepedia

Galit Granot

GG

Statistics

Publications

15

Citations

598

H-Index

14

Active since

2005

Affiliations

Tel Aviv University(Current)

Rabin Medical Center

Edmond and Lily Safra Children's Hospital

Sheba Medical Center

Assuta Medical Center

Galit Granot is an author at Tel Aviv University specializing in oncology, life sciences, and molecular oncology.

Publications per year

2005–2022

15

Publications

15

Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells

Oshrat Hershkovitz‐Rokah, Galit Granot, Adelina Ovcharenko et al. · PLoS ONE · 2012 · 101 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

Oshrat Hershkovitz‐Rokah, Shira Modai, Metsada Pasmanik‐Chor et al. · Cancer Letters · 2014 · 81 citations

Life Sciences, Molecular Biology, Oncology +16

Ponatinib reduces viability, migration, and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Saar Shapira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 73 citations

Medicine, Oncology, Pharmacology +17

Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment

Oshrat Hershkovitz‐Rokah, Shira Modai, Metsada Pasmanik‐Chor et al. · Cancer Letters · 2015 · 63 citations

Life Sciences, Molecular Biology, Oncology +10

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Metsada Pasmanik‐Chor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 62 citations

Medicine, Oncology, Pharmacology +14

1–5 of 15